Vivesto Receives U.S. Orphan Drug Status for Cantrixil
Vivesto says its drug Cantrixil has received orphan drug status in the United States for acute myeloid leukemia.
Related stories
EU court adviser says Google AI chatbot use of news may breach copyright
A European Court of Justice adviser said Google's use of news reports in its AI chatbot may violate copyright rules.
L impact | REGULATION | Nov 03, 2026, 10:52 AM UTC
EU Court Adviser Says Google Gemini Use of Press Items May Infringe Copyright
Advocate General Maciej Szpunar advised the EU’s top court that Google’s use of press stories in Gemini responses can infringe copyright rules in certain circumstances.
L impact | REGULATION | Nov 03, 2026, 10:52 AM UTC
EU Commission Clears JD.com and Ceconomy Deal After Remedies Offered
The EU Commission cleared the deal after JD.com and Ceconomy offered remedies to address competition concerns.
M impact | REGULATION | Nov 03, 2026, 10:45 AM UTC
New York Times Sues Brave Software Over Copyright
The New York Times filed a lawsuit against Brave Software alleging copyright violations.
L impact | REGULATION | Nov 03, 2026, 10:42 AM UTC
US to Require New Document From Air Passengers Starting Nov. 3
The requirement is linked to the Ebola outbreak; the report does not specify the document.
L impact | REGULATION | Nov 03, 2026, 10:34 AM UTC
Taiwan Prepares Tougher Penalties for China’s Transnational Repression
Taiwan is preparing legislation to impose tougher penalties for what it calls China’s transnational repression.
L impact | REGULATION | Nov 03, 2026, 10:33 AM UTC